07. Endocrine and Gastrointestinal 07.001 Diabetic neuropathy is ameliorated in streptozotocin-injected rats after treatment with sulfonylhydrazone derivative. Pereira SL, Souza BJ, Trachez MM, Monteiro CES, Costa FP, Romeiro NC, Lima LM, Barreiro EJ, Sudo RT, Zapata-Sudo G ICB-UFRJ Introduction: Neuropathic pain is a significant cause of impairment among diabetic patients. This study describes the beneficial effects of a novel sulfonylhydrazone derivative (LASSBio- 1473) in a model of diabetes-induced neuropathic pain in rats. Methods: Male Wistar rats (180 – 220 g) received a single intravenous injection of streptozotocin (STZ, 60 mg/kg) to induce diabetes. STZ-treated rats were randomly divided into two groups (n = 5 per group) treated with vehicle (dimethyl sulfoxide, DMSO) or LASSBio-1473 (20 mg/kg, i.p.). These groups were compared with a control group of non-diabetic rats. Plasma glucose levels were examined in blood samples collected by tail-vein puncture, using the Accu-Check®Performa monitoring system. Blood glucose, mechanical allodynia and thermal hyperalgesia were evaluated before and weekly after the STZ injection during 6 weeks. Six weeks after the induction of diabetes, rats with glucose levels >350 mg/dL were treated with either vehicle or LASSBio-1473 for 14 days. After the first administration of vehicle or LASSBio-1473, mechanical allodynia and thermal hyperalgesia were measured 30, 60, 120, 180 and 240 min after injection. Mechanical allodynia and thermal hyperalgesia were examined before and 1, 7, 10 and 15 days after treatment. All data were expressed as mean ± standard error of the mean (SEM). For the comparison of groups, two-way ANOVA was used and differences were considered significant when P was <0.05. The protocols used were approved by Animal Care and Use Committee at Universidade Federal do Rio de Janeiro under DFBCICB 041. Results and discussion: The blood glucose levels of diabetic rats were increased from 126.0 ± 3.4 mg/dL before STZ injection to 555.9 ± 16.9 mg/dL (P< 0.05) at 6 weeks after the induction. Paw withdrawal threshold of diabetic rats was decreased from 41.1 ± 0.3 g before STZ injection to 17.6 ± 1.1 g (P< 0.05) at 6 weeks after the induction. Paw withdrawal latency of diabetic rats was decreased from 10.5 ± 0.6 s before STZ injection to 7.1 ± 0.5 s (P< 0.05) at 6 weeks after the induction. Both alterations indicated the diabetic neuropathy. Sixty minutes after LASSBio-1473 administration, the paw withdrawal threshold increased from 17.1 ± 1.4 g (before injection) to 36.4 ± 1.1 g (P< 0.05). Reduced threshold was observed again after 240 minutes of LASSBio- 1473 administration, when this parameter decreased to 21.6 ± 1.2 g. Also, the paw withdrawal latency increased from 7.3 ± 0.5 s (before injection) to 11.4 ± 0.4 s (P< 0.05) and reduced after 240 minutes of LASSBio-1473 administration, when the paw withdrawal latency decreased to 7.6 ± 0.2 s. Threshold of LASSBio-1473-treated diabetic rats was 17.1 ± 1.4 g before treatment and 34.0 ± 3.1 g after 15 days of treatment (P< 0.05). The paw withdrawal latency of LASSBio- 1473-treated diabetic rats was 7.3 ± 0.5 s before treatment and 10.3 ± 0.4 s after 15 days of treatment (P< 0.05). Vehicle had no effect on mechanical allodynia and thermal hyperalgesia of diabetic rats. The novel sulfonylhydrazone derivative ameliorated mechanical allodynia and thermal hyperalgesia in rats with STZ-induced diabetes. Financial Support: CNPq, FAPERJ, CAPES, INCT, PRONEX. 07.002 Acute toxicity and gastroprotective activity of Cissampelos sympodialis Eichl.(Menispermaceae). Sales IRP, Formiga RO, do Nascimento RF, Lúcio ASSC, Barbosa- Filho JM, Batista LM UFPB Introduction: Cissampelos sympodialis Eichl. (Menispermaceae), popularly known as “milona”, “orelha-de-onça” or “abuteira”, is endemic in Brazil, found in the Northeast and Southeast. Our choice was based on chemotaxonomic criteria because this species is rich in alkaloids (such as warifteine, metilwarifteine and milonine) and showed gastroprotective activity in previous studies. The aim of this study was to evaluate the acute toxicity and gastroprotective activity of total alkaloid fraction obtained from the aerial parts of Cissampelos sympodialis (FAT-Cs). Methods: At trial evaluation of acute toxicity according to OECD 423, female Swiss mices (Mus musculus) (25-35 g, n=3-7) were treated orally (p.o.) with vehicle Tween solution 80 (12%) (negative control), and FAT-Cs (300 or 2000 mg/kg) carried out a behavioral assessment (ALMEIDA, R. N. Rev Bras Far, 80, 72, 1999) and monitoring of animals during a period of 14 days. In the evaluation of the gastroprotective activity male Swiss mices were treated (p.o.) with vehicle Tween solution 80 (12%) (negative control), cimetidine 100 mg/kg (positive control) and FAT-Cs (62.5 125, 250 and 500 mg/kg) and subjected to non-steroidal anti-inflammatory drugs (NSAIDs)-induced ulcer protocol (PUSCAS, I. Arzneimittelforschung, 47, 568, 1997). The data were analyzed using ANOVA, followed by Dunmett’s test. The experimental protocols were approved by the Ethics Committee on Animal Use (CEUA / CBIOTEC / UFPB) with number 0408/12. Results and Discussion: The study of acute toxicity and behavioral assessment the mice treated with 2000 mg/kg of the FAT-Cs showed the presence of analgesia and Straub tail. No death was observed for animals treated with 300 mg / kg of the FAT-Cs, although at a dose of 2000 mg / kg two animals died. Referring to the flowchart values, the estimated lethal dose 50% (LD 50) around 1000 mg / kg according to OECD 423. Treatment with the FAT-Cs (300 mg/kg) did not alter the weight gain, organ weights and water consumption or feed when compared with the negative control group. In ulcer model induced by NSAIDs, the FAT-Cs (62.5 125, 250 and 500 mg/kg) showed protective effect in gastric mucosa with ulcerative index (UI) of 42,71 ± 9,36 , 32,57 ± 9,48, 20,71 ± 8,81 and 18,43 ± 5,53 mm², respectively, when compared to the negative control group (UI: 84,86 ± 19,16 mm²). Thus, the gastroprotective activity already observed earlier may be related to the alkaloids of this species and other studies will elucidate the mechanism of action of the FAT-Cs. Acknowledgments: CNPq/CAPES/PgPNSB /UFPB. 07.003 Acute toxicity and protective effect of Maytenus erythroxylon Reissek (Celastraceae) against ethanol/HCl-induced gastric ulcers in mice. Formiga RO, Caldas Filho MRD, Paulo LL, Quirino ZGM, Batista LM UFPB Introduction: Maytenus erythroxylonReissek is rich in bioactive metabolites from the class of terpenes, anteriorly referenced in the literature as antiulcerogenic (GUTIERREZ, F., J. Nat. Prod., 70, 1049, 2007). This species was selected for this study based on chemotaxonomic criteria that aimed to evaluate the acute toxicity (behavioral assay and Lethal Dose 50%), as well as the gastroprotective property of ethanolic extract obtained from the aerial parts of Maytenus erythroxylon (EEtOH-Me) against gastric ulcers induced by ethanol/HCl. Methods: In the evaluation of acute toxicity (ALMEIDA R.N., Rev. Bras. Farm., 80, 72, 1999) was used male and female Swiss mice (Mus musculus) weighting between 25-35 g (n=3-7) which were divided into 4 groups (2 groups of male animals and 2 groups of female animals) and treated orally (p.o.) with the vehicle NaCl 0.9% (control group) or EEtOH-Me (2000 mg/kg). Then, it was carried out a behavioral assessment and a monitoring of the animals during a period of 14 days, where parameters such as death and water and feed consumption were measured. For the ethanol/HCl-induced gastric ulcers protocol, male Swiss mice were pretreated with vehicle (NaCl 0.9% p.o. - negative control), lansoprazole 30 mg/kg (positive control) and EEtOH-Me (62.5, 125, 250 and 500 mg/kg p.o.). Posteriorly, they were subjected to the harmful agent (Mizui, T., Jap. J. Pharmacol., 33, 934, 1983 – with modifications). The results were analyzed using ANOVA, followed by Dunnett’s test. The experimental protocols were approved by the Ethics Committee on Animal Use (CEUA/CBIOTEC/UFPB) with number 0701/13. Results and Discussion: The EEtOH-Me administered in the single dose of 2000 mg/kg, p.o., induced no apparent changes in the central nervous system and autonomic when compared to the respective control group (saline solution 0.9%). The assessment of water and feed intake showed that the extract did not cause significant increase or decrease of these parameters. There was no death during the experiment and it was also observed no significant changes in animals’ weight or in their organs (heart, kidneys, liver and spleen), as well as the macroscopic characteristics of the animals which received EEtOH-Me, when compared to the control group. In the ethanol/HCl-induced gastric ulcers model the oral doses 250 and 500 mg/kg of the EEtOH-Me presented protective effect in gastric mucosa with ulcerative index of 85.67 ± 10.56 with 32% of injury inhibition (p< 0.01) and 61.80 ± 8.643, 49% (p< 0.001), respectively, when compared to the negative control group (126.7 ± 29.08). Thus, the results of the present study show that ethanolic extract of Maytenus erythroxylon has low toxicity being its LD50 over 2000 mg/kg and it displays gastroprotective activity, as demonstrated by the significant inhibition of ulcer formation. However, future studies are still necessary to evaluate the gastroprotective activity in other induced gastric ulcers models. Acknowlegments: CNPq/CAPES/UFPB. 07.004 Protective effect of Nanuza plicata (Mart.) L. B. Smith & Ayensu (Velloziaceae) against NSAID and stress-induced gastric ulcers in mice.